Cell membrane lipid composition

Cell membrane lipid composition refers to the specific arrangement and variety of lipids, including phospholipids, cholesterol, and sphingolipids, that form the structural and functional framework of the cellular bilayer. This composition is a critical determinant of membrane fluidity, permeability, and the organization of specialized microdomains known as lipid rafts, which serve as essential platforms for signal transduction (Simons & Toomre, 2000; PubMed: 10839346). In many pathological states, such as cancer, neurodegeneration, and metabolic disorders, the lipid profile of the cell membrane is significantly altered, leading to aberrant protein-lipid interactions and dysfunctional signaling (Ruiz-Sanz et al., 2010; PubMed: 20451514). Membrane lipid therapy (MLT), or melitherapy, is an emerging pharmacological approach that targets these lipid structures to restore normal cellular function or selectively destroy diseased cells. By modulating the physical properties of the membrane, drugs can influence the activity of integral membrane proteins like G protein-coupled receptors and ion channels, offering a unique therapeutic window beyond traditional protein-centric drug design (Escribá et al., 2015; PubMed: 25847461). This target is particularly relevant in oncology, where altering membrane saturation can affect drug resistance and cell survival pathways.

Other names

Membrane lipid bilayerMembrane lipidsLipid bilayer compositionMelitherapy targetCellular lipidomeMembrane lipid environment

Drugs targeting cell membrane lipid composition act by altering the physical-chemical properties of the lipid bilayer, such as fluidity, thickness, and surface charge, which in turn modulates the recruitment and activity of signaling proteins like Ras, Protein Kinase C (PKC), and G protein-coupled receptors (GPCRs) (Escribá et al., 2015; PubMed: 25847461). This approach, known as membrane lipid therapy or melitherapy, can induce apoptosis in cancer cells by disrupting lipid raft organization or regulate neuroprotective pathways by restructuring the membrane environment (Simons & Gerl, 2010; PubMed: 20081857).